We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
-5.88%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$583M
AUM Growth
-$42M
Cap. Flow
+$4.78M
Cap. Flow %
0.82%
Top 10 Hldgs %
24.86%
Holding
234
New
30
Increased
81
Reduced
96
Closed
19

Top Sells

Rank Stock Value
1
WSM icon
Williams-Sonoma
WSM
+$5.15M
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$3.95M
3
CSCO icon
Cisco
CSCO
+$3.17M
4
DBX icon
Dropbox
DBX
+$2.89M
5
MU icon
Micron Technology
MU
+$2.29M

Sector Composition

Rank Sector Weight
1 Healthcare 19.13%
2 Technology 14.13%
3 Industrials 7.82%
4 Communication Services 6.8%
5 Energy 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHD icon
226
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.42B
-10,887
Closed -$481K
TNDM icon
227
Tandem Diabetes Care
TNDM
$1.62B
-5,863
Closed -$347K
VEA icon
228
Vanguard FTSE Developed Markets ETF
VEA
$239B
-7,488
Closed -$306K
VOD icon
229
Vodafone
VOD
$37.3B
-29,040
Closed -$452K
VTV icon
230
Vanguard Morningstar Value ETF
VTV
$194B
-2,865
Closed -$378K
WMT icon
231
Walmart Inc
WMT
$920B
-6,366
Closed -$258K
PETQ
232
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-32,112
Closed -$539K
STOR
233
DELISTED
STORE Capital Corporation
STOR
-56,240
Closed -$1.47M
SWIR
234
DELISTED
Sierra Wireless
SWIR
-63,706
Closed -$1.49M

Similar funds

Greenwood Capital Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Greenwood Capital Associates held 234 positions worth $583M, down 6.7% from $625M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q3 2022 filing shows 30 new, 81 increased, 96 reduced and 19 closed positions. Its largest new stake was CRISPR Therapeutics: 60,055 shares worth $3.92M. The largest sale was Williams-Sonoma, an estimated $5.15M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Greenwood Capital Associates's largest Q3 2022 buy was CRISPR Therapeutics: 60,055 shares worth $3.92M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $4.77M increase.
  • Greenwood Capital Associates's biggest Q3 2022 reduction was Williams-Sonoma, cutting an estimated $5.15M.
  • Greenwood Capital Associates fully exited Electronic Arts in Q3 2022, selling an estimated $1.69M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $583M portfolio in Q3 2022.
  • Greenwood Capital Associates opened 30 new positions and closed 19 in Q3 2022.
  • Greenwood Capital Associates's portfolio value fell 6.7% quarter-over-quarter to $583M.

Based on Greenwood Capital Associates's 13F filing for Q3 2022, filed 10 Nov 2022.